Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab.

Haematologica

Volumn 91, Issue 5 Suppl, 2006, Pages

  Cheung, Winnie W ^a   Hwang, Gloria Y ^a   Tse, Eric ^a   Kwong, Yok Lam ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIVIRUS AGENT; AZATHIOPRINE; CANCER ANTIBODY; CD52 ANTIGEN; DRUG DERIVATIVE; GANCICLOVIR; GLYCOPROTEIN; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; PREDNISOLONE; RITUXIMAB; TUMOR ANTIGEN; VALGANCICLOVIR;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD TRANSFUSION; CASE REPORT; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; DRUG EFFECT; DRUG RESISTANCE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PHYSIOLOGY; REMISSION; SPLENECTOMY; VIREMIA; VIRUS ACTIVATION;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, CD; ANTIGENS, NEOPLASM; ANTIVIRAL AGENTS; AZATHIOPRINE; BLOOD TRANSFUSION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE; GANCICLOVIR; GLYCOPROTEINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREDNISOLONE; REMISSION INDUCTION; SPLENECTOMY; VIREMIA; VIRUS ACTIVATION;

EID: 33745941145     PISSN: None     EISSN: 15928721     Source Type: Journal    
DOI: None     Document Type: Article

References (0)